Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,978 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Not Yet Recruiting

A Phase I/II Study of TRS005 in Combination With Cyclophosphamide, Doxorubicin, and Prednisone（T-CHP） in Previously Untreated Patients With CD20-positive DLBCL

NCT07035379

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Chinese Academy of Medical Sciences, Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological Malignancies

NCT07131449

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Impact of a mHealth Supportive Tool on Cardiopulmonary Resuscitation' Situational Awareness

NCT04464603

Conditions: Cardiopulmonary Arrest, Cardiovascular Diseases, Heart Arrest, +14 more
Locations: Geneva Children's Hospital, Geneva University Hospitals Geneva, Canton of Geneva, Switzerland

View Trial Details

Not Yet Recruiting

Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL

NCT05779930

Conditions: Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia, in Relapse, B Cell Leukemia, +22 more
Locations: Nationwide Children's Hospital Columbus, Ohio, United States

View Trial Details

Not Yet Recruiting

G-Pola-ZLP in Diffuse Large B-Cell Lymphoma

NCT06665217

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies

NCT07113496

Conditions: B-cell Acute Lymphoblastic Leukemia (B-ALL), Blood Protein Disorders, Burkitt Lymphoma, +34 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation

NCT07117305

Conditions: CD7+ Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: The First Affiliated Hospital of Zhengzhou University, Department of Oncology Zhengzhou, Henan, China

View Trial Details

Not Yet Recruiting

BCMA/CD3 BsAb Therapy for POEMS Syndrome

NCT07115654

Conditions: Abnormalities, Multiple, Blood Protein Disorders, Congenital Abnormalities, +11 more
Locations: Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Not Yet Recruiting

RN1201 Injection in Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma

NCT07114432

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China

Tianjin Cancer Hospital Airport Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia

NCT07113132

Conditions: Acute Lymphoblastic Leukemia ALL, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +16 more
Locations: Not specified

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions